A map of what has been tested in rats and mice — gut, tendon, muscle, vessel, nerve, brain — and what kind of result each model gives

Published 26 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
Gastrointestinal: ethanol and drug-induced gastric lesions, colitis, fistulas, anastomosis healing, short bowel — the original and largest group. Musculoskeletal: Achilles tendon transection, medial collateral ligament injury, muscle crush and transection, bone defects. Vascular: venous occlusion models, vessel injury, the group proposal of collateral vessel recruitment. Nervous: sciatic nerve injury, brain injury models, and a set of behavioural studies on drug effects. Each model reports an outcome — lesion area, biomechanical strength, histology, functional score — in treated and control animals, and the treated group is favoured in nearly every published report. The models are standard, the animal numbers modest, and independent replication rare.

What the models can show

A standardised injury in a rat with and without the peptide gives a controlled comparison on a defined endpoint. Tendon studies measure load to failure and histological organisation; gut studies measure lesion area and healing; nerve studies measure conduction or function. These are legitimate preclinical designs and the endpoints are objective.

They establish what happens in that model under those conditions and nothing more.

The pattern and its reading

Positive results across nearly every system from one laboratory lineage is a pattern that can mean a broadly active molecule or a literature with publication and investigator effects, and the two cannot be told apart from inside the literature. The absence of published human trial results, despite the compound having been in trials, leaves the question where it was. A reader should hold both possibilities.

The Chang 2011 tendon fibroblast work, from a Taiwanese group, is among the few independent mechanistic contributions.

Why it is here

Because the shape of a literature matters as much as its contents, and this one has a distinctive shape. It describes studies and no use of the pack.

The BPC-157 + TB500 blend is supplied by REVIVE LAB UAE for laboratory research use only, with identity by mass spectrometry and purity by HPLC for each component of the batch. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
BPC-157 + TB500 Pack5 mg + 5 mgAED 510In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

What the models can show?

A standardised injury in a rat with and without the peptide gives a controlled comparison on a defined endpoint. Tendon studies measure load to failure and histological organisation; gut studies measure lesion area and healing; nerve studies measure conduction or function. These are legitimate preclinical designs and the endpoints are objective.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

BPC-157 + TB500 Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.